{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:12:01Z","timestamp":1793459521870,"version":"4.5.0"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005668","name":"Funda\u00ef\u00bf\u00bd\u00ef\u00bf\u00bdo de Apoio \u00ef\u00bf\u00bd Pesquisa do Distrito Federal","doi-asserted-by":"publisher","award":["0193.000827\/2015"],"award-info":[{"award-number":["0193.000827\/2015"]}],"id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02927","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T23:16:35Z","timestamp":1578525395000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":84,"title":["Lysophosphatidylcholine Induces NLRP3 Inflammasome-Mediated Foam Cell Formation and Pyroptosis in Human Monocytes and Endothelial Cells"],"prefix":"10.3389","volume":"10","author":[{"given":"Rafael","family":"Corr\u00eaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Felipe Fonseca","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila Juliana Silva","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel das Neves","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor de Oliveira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Henrique","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Pimentel","family":"de Sant'Ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Santos","family":"Assun\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia T.","family":"Bozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly Grace","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis","volume":"209","author":"Tabas","year":"2015","journal-title":"J Cell Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13238-012-2025-6","article-title":"Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis","volume":"3","author":"Yuan","year":"2012","journal-title":"Protein Cell."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.2174\/092986707782793899","article-title":"Role of lysophosphatidylcholine (LPC) in atherosclerosis","volume":"14","author":"Matsumoto","year":"2007","journal-title":"Curr Med Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.ATV.3.2.149","article-title":"Enhanced macrophage degradation of biologically modified low density lipoprotein","volume":"3","author":"Henriksen","year":"1983","journal-title":"Arterioscler Anal."},{"key":"B6","first-page":"57","article-title":"Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages","volume":"100","author":"Schaffner","year":"1980","journal-title":"Am J Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1083\/jcb.82.3.597","article-title":"Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins","volume":"82","author":"Brown","year":"1979","journal-title":"J Cell Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1172\/JCI115932","article-title":"Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells","volume":"90","author":"Kume","year":"1992","journal-title":"J Clin Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1073\/pnas.85.8.2805","article-title":"Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis","volume":"85","author":"Quinn","year":"1988","journal-title":"Proc Natl Acad Sci USA."},{"key":"B10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.05.029","article-title":"Metabolism and atherogenic disease association of lysophosphatidylcholine","volume":"208","author":"Schmitz","year":"2010","journal-title":"Atherosclerosis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1161\/01.ATV.0000246774.02426.71","article-title":"Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice","volume":"26","author":"Parks","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"33483","DOI":"10.1074\/jbc.M804628200","article-title":"Analyses of group III secreted phospholipase A 2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis","volume":"283","author":"Sato","year":"2008","journal-title":"J Biol Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1161\/01.ATV.17.7.1258","article-title":"Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells","volume":"17","author":"Hara","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1086\/656477","article-title":"Schistosomal-derived lysophosphatidylcholine are involved in eosinophil activation and recruitment through toll-like receptor\u22122\u2013dependent mechanisms","volume":"202","author":"Magalh\u00e3es","year":"2010","journal-title":"J Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.3389\/fimmu.2018.03161","article-title":"Schistosomal Lipids activate human eosinophils via toll-like receptor 2 and PGD2 receptors: 15-LO role in cytokine secretion","volume":"9","author":"Magalh\u00e3es","year":"2019","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/01.RES.83.5.508","article-title":"Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes","volume":"83","author":"Nishi","year":"1998","journal-title":"Circ Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1749-6632.2001.tb03952.x","article-title":"Lysophosphatidylcholine inhibits T cell-specific CXC chemokines IP-10, MIG, and I-TAC expression induced by IFN-\u03b3 in human endothelial cells","volume":"947","author":"Sheikh","year":"2006","journal-title":"Ann N Y Acad Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/01.RES.80.5.638","article-title":"Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor\u2013like growth factor in human T lymphocytes","volume":"80","author":"Nishi","year":"1997","journal-title":"Circ Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/jb\/mvv044","article-title":"Lysophosphatidylcholine promotes SREBP-2 activation via rapid cholesterol efflux and SREBP-2-independent cytokine release in human endothelial cells","volume":"158","author":"Morita","year":"2015","journal-title":"J Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbalip.2016.11.006","article-title":"Schistosomal-derived lysophosphatidylcholine triggers M2 polarization of macrophages through PPAR\u03b3 dependent mechanisms","volume":"1862","author":"Assun\u00e7\u00e3o","year":"2017","journal-title":"Biochim Biophys Acta."},{"key":"B21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.bbalip.2009.01.005","article-title":"Leukocyte lipid bodies \u2014 Biogenesis and functions in inflammation","volume":"1791","author":"Bozza","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1172\/JCI46069","article-title":"The role of lipid droplets in metabolic disease in rodents and humans","volume":"121","author":"Greenberg","year":"2011","journal-title":"J Clin Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH","volume":"58","author":"Ioannou","year":"2017","journal-title":"J Lipid Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/eurheartj\/ehv653","article-title":"Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque","volume":"37","author":"Janoudi","year":"2016","journal-title":"Eur Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/path.4873","article-title":"Cholesterol crystallization in human atherosclerosis is triggered in smooth muscle cells during the transition from fatty streak to fibroatheroma","volume":"241","author":"Ho-Tin-No\u00e9","year":"2017","journal-title":"J Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.redox.2016.12.005","article-title":"ROS via BTK-p300-STAT1-PPAR\u03b3 signaling activation mediates cholesterol crystals-induced CD36 expression and foam cell formation","volume":"11","author":"Kotla","year":"2017","journal-title":"Redox Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41232-017-0050-9","article-title":"The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis","volume":"37","author":"Karasawa","year":"2017","journal-title":"Inflamm Regen."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS ONE."},{"key":"B30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell."},{"key":"B31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature."},{"key":"B33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","article-title":"Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration","volume":"14","author":"P\u00e9trilli","year":"2007","journal-title":"Cell Death Differ."},{"key":"B35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.smim.2009.05.002","article-title":"The NLRP3 inflammasome: a sensor of immune danger signals","volume":"21","author":"Cassel","year":"2009","journal-title":"Semin Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijcard.2017.05.016","article-title":"Statin regulates NLRP1 inflammasome expression through SREBP1: a novel anti-atherosclerotic mechanism","volume":"247","author":"Yu","year":"2017","journal-title":"Int J Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1016\/j.jacc.2017.09.028","article-title":"Interleukin-1 beta as a target for atherosclerosis therapy","volume":"70","author":"Libby","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2017.10.027","article-title":"NLRP3 inflammasome pathways in atherosclerosis","volume":"267","author":"Baldrighi","year":"2017","journal-title":"Atherosclerosis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12944-017-0595-2","article-title":"Study of the NLRP3 inflammasome component genes and downstream cytokines in patients with type 2 diabetes mellitus with carotid atherosclerosis","volume":"16","author":"Lee","year":"2017","journal-title":"Lipids Health Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0188387","DOI":"10.1371\/journal.pone.0188387","article-title":"Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation","volume":"12","author":"Gregersen","year":"2017","journal-title":"PLoS ONE."},{"key":"B41","doi-asserted-by":"publisher","first-page":"154215","DOI":"10.1016\/j.cyto.2017.11.009","article-title":"IL-1 family cytokines in cardiovascular disease","volume":"122","author":"Pfeiler","year":"2017","journal-title":"Cytokine."},{"key":"B42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fphys.2018.00114","article-title":"Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications","volume":"9","author":"Sharma","year":"2018","journal-title":"Front Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"8560","DOI":"10.4049\/jimmunol.177.12.8560","article-title":"Lysophosphatidylcholine stimulates IL-1\u03b2 release from microglia via a P2X 7 receptor-independent mechanism","volume":"177","author":"Stock","year":"2006","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0021-9150(97)00295-5","article-title":"Lysophosphatidylcholine induces the production of IL-1\u03b2 by human monocytes","volume":"137","author":"Liu-Wu","year":"1998","journal-title":"Atherosclerosis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1046\/j.1365-2249.1999.00871.x","article-title":"Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism","volume":"116","author":"Huang","year":"1999","journal-title":"Clin Exp Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1210\/endo.137.10.8828503","article-title":"Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro","volume":"137","author":"Spangelo","year":"1996","journal-title":"Endocrinology."},{"key":"B48","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00011-013-0667-3","article-title":"OxLDL-induced IL-1beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation","volume":"63","author":"Liu","year":"2014","journal-title":"Inflamm Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.4049\/jimmunol.1000803","article-title":"Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia","volume":"185","author":"Lamkanfi","year":"2010","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cyto.2014.03.007","article-title":"How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1","volume":"69","author":"Keyel","year":"2014","journal-title":"Cytokine."},{"key":"B52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJM200507283530425","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"353","author":"Hansson","year":"2005","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1161\/ATVBAHA.107.161174","article-title":"Chemokines in atherosclerosis","volume":"28","author":"Zernecke","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin Chim Acta."},{"key":"B56","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.micron.2005.10.007","article-title":"Monocyte recruitment and foam cell formation in atherosclerosis","volume":"37","author":"Bobryshev","year":"2006","journal-title":"Micron."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/79510","article-title":"The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals","volume":"6","author":"Kureishi","year":"2000","journal-title":"Nat Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The Mechanisms of Action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu Rev Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(00)81575-5","article-title":"PPAR\u03b3 promotes monocyte\/macrophage differentiation and uptake of oxidized LDL","volume":"93","author":"Tontonoz","year":"1998","journal-title":"Cell."},{"key":"B60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/cbf.1374","article-title":"Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPAR\u03b3-LXR\u03b1-ABCA1-dependent pathway associated with apoE","volume":"25","author":"Hou","year":"2007","journal-title":"Cell Biochem Funct."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1084\/jem.20150237","article-title":"NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes","volume":"214","author":"Freeman","year":"2017","journal-title":"J Exp Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jneuroim.2017.07.004","article-title":"Lysophosphatidylcholine activates caspase-1 in microglia via a novel pathway involving two inflammasomes","volume":"310","author":"Scholz","year":"2017","journal-title":"J Neuroimmunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.bbalip.2015.08.009","article-title":"Electronegative LDL induces priming and inflammasome activation leading to IL-1\u03b2 release in human monocytes and macrophages","volume":"1851","author":"Estruch","year":"2015","journal-title":"Biochim Biophys Acta."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e87552","DOI":"10.1371\/journal.pone.0087552","article-title":"Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e76233","DOI":"10.1371\/journal.pone.0076233","article-title":"Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-\u03baB translocation and MAPK\/ERK phosphorylation","volume":"8","author":"Carneiro","year":"2013","journal-title":"PLoS ONE."},{"key":"B66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cellimm.2010.08.003","article-title":"Importance of lipid rafts for lysophosphatidylcholine-induced caspase-1 activation and reactive oxygen species generation","volume":"265","author":"Schilling","year":"2010","journal-title":"Cell Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"106177","DOI":"10.18632\/oncotarget.22425","article-title":"Lysophosphatidylcholine induces cytotoxicity\/apoptosis and IL-8 production of human endothelial cells: related mechanisms","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget."},{"key":"B68","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat Rev Microbiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/ni.1960","article-title":"Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria","volume":"11","author":"Miao","year":"2010","journal-title":"Nat Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature."},{"key":"B71","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e1002452","DOI":"10.1371\/journal.ppat.1002452","article-title":"Inflammasome-dependent pyroptosis and IL-18 protect against burkholderia pseudomallei lung infection while IL-1\u03b2 is deleterious","volume":"7","author":"Ceballos-Olvera","year":"2011","journal-title":"PLoS Pathog."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41374-018-0073-0","article-title":"NLRP3\/ASC-mediated alveolar macrophage pyroptosis enhances HMGB1 secretion in acute lung injury induced by cardiopulmonary bypass","volume":"98","author":"Hou","year":"2018","journal-title":"Lab Investig."},{"key":"B75","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-62703-523-1-7","article-title":"Detection of pyroptosis by measuring released lactate dehydrogenase activity","volume":"1040","author":"Rayamajhi","year":"2013","journal-title":"Methods Mol Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.intimp.2018.12.028","article-title":"Role of pyroptosis in cardiovascular diseases","volume":"67","author":"Jia","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"17485","DOI":"10.1074\/jbc.M115.641191","article-title":"Inhibition of caspase-1 activation in endothelial cells improves angiogenesis","volume":"290","author":"Lopez-Pastrana","year":"2015","journal-title":"J Biol Chem."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T23:16:38Z","timestamp":1578525398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":77,"alternative-id":["10.3389\/fimmu.2019.02927"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02927","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"article-number":"2927"}}